X0306 4 2019-04-08 0 0001426332 NGM BIOPHARMACEUTICALS INC NGM 0001347769 COLUMN GROUP L P 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 0 0 1 0 0001600420 COLUMN GROUP II, LP 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 0 0 1 0 0001614627 COLUMN GROUP GP, LP 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 0 0 1 0 0001645340 Column Group Management LP 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 0 0 1 0 0001645333 Column Group II GP, LP 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 0 0 1 1 General Partner 0001707230 PONOI CAPITAL, LP 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 0 0 1 0 0001720702 Ponoi Management, LLC 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 0 0 1 1 General Partner 0001732601 Ponoi Capital II, LP 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 0 0 1 0 0001746488 Ponoi II Management, LLC 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 0 0 1 1 General Partner 0001614186 Kutzkey Tim 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 0 0 1 1 Managing Partner Common Stock 2019-04-08 4 C 0 13093134 A 13569091 D Common Stock 2019-04-08 4 P 0 1875000 16.00 A 1875000 D Common Stock 2019-04-08 4 P 0 15000 16.00 A 15000 D Series A Preferred Stock 2019-04-08 4 C 0 12000000 0.00 D Common Stock 6000000 0 D Series B Preferred Stock 2019-04-08 4 C 0 8408933 0.00 D Common Stock 4204467 0 D Series C Preferred Stock 2019-04-08 4 C 0 2377334 0.00 D Common Stock 1188667 0 D Series D Preferred Stock 2019-04-08 4 C 0 3400000 0.00 D Common Stock 1700000 0 D Every two shares of Series A preferred stock, Series B preferred stock, Series C preferred stock and Series D preferred stock automatically converted into one share of common stock in connection with the closing of the issuer's initial public offering, without payment of consideration. These shares have no expiration date. Consists of 11,103,333 shares of Common Stock held directly by The Column Group, LP ("TCG LP"), 2,265,758 shares of Common Stock held directly by The Column Group II, LP ("TCG II LP"), 100,000 shares of Common Stock held directly by The Column Group GP, LP ("TCG GP") and 100,000 shares of Common Stock held directly by The Column Group Management, LP ("TCGM LP"). The securities are directly held by TCG LP, and indirectly held by TCG GP, the general partner of TCG LP. The managing partners of TCG GP are David Goeddel and Peter Svennilson. The managing partners of TCG GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares. The securities are directly held by TCG II LP, and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares. The securities are directly held by TCG GP. The managing partners of TCG GP are David Goeddel and Peter Svennilson. The managing partners of TCG GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares. The securities are directly held by TCGM LP. The managing partners of TCGM LP are David Goeddel and Peter Svennilson. The managing partners of TCGM LP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares. Consists of 937,500 shares of Common Stock held directly by Ponoi Capital, LP ("Ponoi LP") and 937,500 shares of Common Stock held directly by Ponoi Capital II, LP ("Ponoi II LP"). The securities are directly held by Ponoi LP, and indirectly held by Ponoi Management, LLC ("Ponoi LLC"), the general partner of Ponoi LP. The managing partners of Ponoi LLC are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of Ponoi LLC may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares. The securities are directly held by Ponoi II LP, and indirectly held by Ponoi II Management, LLC ("Ponoi II LLC"), the general partner of Ponoi II LP. The managing partners of Ponoi II LLC are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of Ponoi II LLC may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares. These securities are owned solely by Tim Kutzkey. Consists of 7,200,000 shares of Series B Preferred Stock that were convertible into 3,600,000 shares of Common Stock held directly by TCG LP and 1,208,933 shares of Series B Preferred Stock that were convertible into 604,467 shares of Common Stock held directly by TCG II LP. Consists of 2,340,000 shares of Series C Preferred Stock that were convertible into 1,170,000 shares of Common Stock held directly by TCG LP and 37,334 shares of Series C Preferred Stock that were convertible into 18,667 shares of Common Stock held directly by TCG II LP. Consists of 666,666 shares of Series D Preferred Stock that were convertible into 333,333 shares of Common Stock held directly by TCG LP and 2,733,334 shares of Series D Preferred Stock that were convertible into 1,366,667 shares of Common Stock held directly by TCG II LP. /s/ Jennifer J. Carlson, Attorney-in-Fact 2019-04-10